Tumour-infiltrating lymphocytes, especially cytotoxic CD8+ T-cells, are associated with response to checkpoint inhibitors in several tumour entities such as melanoma and ovarian carcinoma (Almeida et al., 2020; Raskov et al., 2021). Here, CD8A is linked to neoplasm.